Journal of Clinical Medicine
Effects of UroVaxom on Urinary Tract Infection After Ureteroscopic Lithotripsy: A Multicenter Prospective Randomized Study
By S Lee, Kyung Jin Oh, Ho Seok Chung and 4 others.
Abstract
Background/Objectives: To evaluate whether perioperative UroVaxom reduces postoperative urinary tract infection-related findings after ureteroscopic lithotripsy.
Methods
In this prospective, randomized, multicenter study, patients with a history of recurrent UTI who were scheduled to undergo ureteroscopic lithotripsy for unilateral renal or ureteral stones < 2 cm were assigned to UroVaxom 60 mg or placebo once daily for 1 week before and 2 weeks after surgery. Baseline characteristics, surgical outcomes, postoperative UTI, pyuria, bacteriuria, serum C-reactive protein (CRP), and adverse events were compared.